BON Announces Apple Polyphenol Commercial Order Signed
April 11 2025 - 7:00AM
Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a
leading bio-ingredient solution provider in the natural, health and
personal care industry, announced a groundbreaking 24-month supply
agreement worth $12M with Shanghai Yunsheng, China's premier
functional ingredients distributor, to co-develop next-generation
apple polyphenol-infused health solutions. The partnership
leverages BON's patented extraction technology to deliver
science-backed formulations combining antioxidant-rich apple
polyphenols with plant-based proteins, proven to support weight
management and metabolic health.
Protein supplements have evolved into a
mainstream wellness staple over decades, cementing their role in
fitness regimens, immune health protocols, and longevity-focused
nutrition. The strategic incorporation of apple polyphenols into
these formulations now unlocks targeted benefits-clinically
validated lipid management, enhanced body composition outcomes, and
mitigation of age-related muscle atrophy-positioning this
innovation at the convergence of proven demand and novel
functionality.
Early market validation proves
compelling-comparable apple polyphenol blends have achieved
blockbuster status since launch, selling over half a million units
monthly and generating $40M in recurring revenue. Industry analysts
note this reflects growing consumer willingness to pay premium
pricing for validated "nutraceutical crossover" products.
“As one of the world's premier apple polyphenol
suppliers, we're leveraging our vertically integrated supply chain
to dominate this high-growth niche,” said Yongwei Hu, Chairman and
CEO of the Company, “the company anticipates compounding revenue
streams from the ingredient's dual applications-both as a
standalone nutraceutical and as a functional food additive-while
maintaining disciplined margin control to maximize shareholder
returns.”
About Bon Natural Life Limited
("BON")
BON is a Cayman Islands company engaged in the
business of natural, health, and personal care industries. For more
information, please visit the Company's website at
http://www.bnlus.com.
For more information, please contact:
Cindy Liu | IR Email: bonnatural@appchem.cn
Safe Harbor Statement
This press release contains certain statements
that may include "forward-looking statements." All statements other
than statements of historical fact included herein are
"forward-looking statements." These forward-looking statements are
often identified by the use of forward-looking terminology such as
"believes," "expects" or similar expressions, involve known and
unknown risks and uncertainties. Although the Company believes that
the expectations reflected in such forward-looking statements are
reasonable, they do involve assumptions, risks, and uncertainties,
and these expectations may prove to be incorrect. You should not
place undue reliance on these forward-looking statements, which
speak only as of the date of this press release. The Company's
actual results could differ materially from those anticipated in
these forward-looking statements as a result of a variety of
factors, including those discussed in the Company's periodic
reports that are filed with the Securities and Exchange Commission
and available on its website (http://www.sec.gov). All
forward-looking statements attributable to the Company or persons
acting on its behalf are expressly qualified in their entirety by
these factors. Other than as required under the securities laws,
the Company does not assume a duty to update these forward-looking
statements.
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From Apr 2025 to May 2025
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From May 2024 to May 2025